The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the primary target of many drug discovery efforts and is similarly utilized in each of the approved COVID-19 ...
In a recent article published in Scientific Reports, researchers performed immunoglobulin (Ig)M and IgG epitope mapping against 487 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
ProImmune Ltd has launched the REVEAL™ B Cell Epitope Discovery System, a service designed to accelerate the development of biological therapies and understanding of diseases at a structural level.
Epitope information is increasingly being used to understand the mechanism of action (MoA) of therapeutic monoclonal antibodies (mAbs), as well as to overcome the mounting challenges of patenting them ...
Mapping of epitopes recognized by functional monoclonal antibodies (mAbs) is essential for understanding the nature of immune responses and designing improved vaccines, therapeutics, and diagnostics.
Antigenic forms of high interest often keep a low profile, frustrating investigators who would like to identify and characterize epitopes, the parts of antigens that are recognized by antibodies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback